Results 91 to 100 of about 16,319 (214)

Clinical Study on the Association Between Lipoprotein(a) Levels and Prognosis in Patients With Acute Ischemic Stroke

Brain and Behavior, Volume 16, Issue 5, May 2026.
Elevated lipoprotein(a) is independently associated with poor 3‐month outcomes in acute ischemic stroke. Combining Lp(a) with NIHSS improves prognostic accuracy. ABSTRACT Background Lipoprotein(a) (Lp(a)) is a known cardiovascular risk factor, but its role in acute ischemic stroke (AIS) prognosis remains unclear. This study investigated the association
Xinyi Chen, Yueyu Zhang, Yi Tang, Jie Hu, Xun He, Juncang Wu   +5 more
wiley   +1 more source

Patent foramen ovale and stroke: prognosis and treatment in young adults. [PDF]

, 2005
A patent foramen ovale (PFO) is found with increased frequency in patients with stroke of undetermined origin but the significance and therapeutic implications of this observation remain unclear.
Cramer, Steven C
core   +1 more source

Forecasting Vascular Risk Factors in Young Ischemic Stroke Patients: A Two‐Decade Perspective From Spain

European Journal of Neurology, Volume 33, Issue 5, May 2026.
Using the Spanish Minimum Basic Data Set (2000–2022), 57,427 young adults (18–50 years) hospitalized with ischemic stroke were analyzed. Incidence increased from 7 to 15 per 100,000 population, accompanied by marked rises in obesity (5.2% → 15.2%), illicit substance use (1% → 13.5%), and cardiac comorbidities. Short‐term forecasts (2023–2027) suggest a
Tania Garrido‐Hernández, Laura Amaya‐Pascasio, Adrián Aparicio‐Mota, José María López‐Martín, Patricia Martínez‐Sánchez   +4 more
wiley   +1 more source

Associating cryptogenic ischemic stroke in the young with cardiovascular risk factor phenotypes

Scientific Reports, 2021
Acute Ischemic Stroke (AIS) in the young is increasing in prevalence and the largest subtype within this cohort is cryptogenic. To curb this trend, new ways of defining cryptogenic stroke and associated risk factors are needed.
Joseph M. Dardick, David Flomenbaum, Daniel L. Labovitz, Natalie Cheng, Ava L. Liberman, Charles Esenwa   +5 more
doaj   +1 more source

Clinical Outcomes and Non‐Invasive Testing in Metabolic Dysfunction‐Associated Steatohepatitis With Cirrhosis: A Systematic Review

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatohepatitis (MASH) with cirrhosis lacks definitive treatments and poses an increasing healthcare burden globally. We undertook a systematic literature review (SLR) to better understand the disease burden in cirrhosis due to MASH.
Hannes Hagström, Chris Hellmund, Jeffrey V. Lazarus, Riku Ota, Mary E. Rinella, Giada Sebastiani, Fotis Tefos, Zobair M. Younossi, Mazen Noureddin   +8 more
wiley   +1 more source

Atrial high-rate episodes and stroke prevention. [PDF]

, 2017
While the benefit of oral anticoagulants (OACs) for stroke prevention in patients with atrial fibrillation (AF) is well established, it is not known whether oral anticoagulation is indicated in patients with atrial high-rate episodes (AHRE) recorded on a
A. John Camm, Ahmad, Alhadramy, Anderson, Andreas Goette, Aronsson, Benezet-Mazuecos, Benezet-Mazuecos, Boriani, Boriani, Boriani, Botto, Botto, Brambatti, Camm, Camm, Camm, Camm, Chen-Scarabelli, Chiti, Connolly, Connolly, Daoud, Defaye, Dion, Doliwa Sobocinski, Emmanuel Simantirakis, Flaker, Freestone, Friberg, Giugliano, Gladstone, Glotzer, Glotzer, Glotzer, Goldsmith, Gonzalez, Granger, Gregory Chlouverakis, Gregory Y.H. Lip, Grond, Guo, Hannon, Hans-Christoph Diener, Hart, Healey, Healey, Hijazi, Hijazi, Inoue, Jorfida, Kerr, Kirchhof, Kirchhof, Kirchhof, Kirchhof, Kishore, Lamassa, Lip, Lip, Martin, Melanie Calvert, Mittal, NCT01706146, NCT01938248, Ohara, Orlov, Page, Palm, Panos Vardas, Patel, Patten, Paulus Kirchhof, Pollak, Potpara, Rizos, Rosiak, Ruff, Sanna, Savelieva, Savelieva, Savelieva, Savelieva, Shanmugam, Singer, Skanes, Swiryn, Tayal, Todd, Varma, Vilchez, Warraich, Watson, Weigner, WHO, Wiesel, Wolf, You   +97 more
core   +1 more source

Diagnosis and Management of Patent Foramen Ovale for Stroke Prevention: An Australian and New Zealand Consensus Statement Developed by a Modified Nominal Group Approach

Medical Journal of Australia, Volume 224, Issue 5, May 2026.
ABSTRACT Introduction Patent foramen ovale (PFO) is implicated in 25%–50% of cryptogenic strokes in patients aged < 60 years. Recent clinical trials demonstrated the benefit of PFO closure in selected patients. However, there is considerable variability in Australian and New Zealand clinical practice regarding investigation and management approaches. A
Brian R. Chambers, Lauren M. Sanders, Amanda Gilligan, Carlos Garcia‐Esperon, Jan Ho, John Fink, Matias Yudi, Matthew Lee‐Archer, Vimal Stanislaus, Andrew A. Wong   +9 more
wiley   +1 more source

Diagnostic Utility of N-Terminal Pro-B-Type Natriuretic Peptide in Identifying Atrial Fibrillation Post-Cryptogenic Stroke: A Systematic Review and Meta-Analysis

Pathophysiology
Background: Atrial fibrillation (AF) significantly contributes to acute ischemic stroke, with undetected AF being a common culprit in cryptogenic strokes.
Jay Patel, Sonu M. M. Bhaskar
doaj   +1 more source

CT angiography of the aorta is superior to transesophageal echocardiography for determining stroke subtypes in patients with cryptogenic ischemic stroke [PDF]

, 2012
Background: The etiology of ischemic strokes remains cryptogenic in about one third of patients, even after extensive workup in specialized centers. Atherosclerotic plaques in the aorta can cause thromboembolic events but are often overlooked.
Artemis, Dimitrios, Chatzikonstantinou, Anastasios, Fink, Christian, Flüchter, Stephan, Hennerici, Michael G., Krissak, Radko, Schäfer, A., Schönberg, Stefan O.   +7 more
core   +1 more source

Genetic Diagnosis and Discovery Enabled by Large Language Models

Advanced Science, Volume 13, Issue 22, 17 April 2026.
We demonstrate that large language models (LLMs) can facilitate genetic diagnosis and discovery. LLMs were used to solve four types of genetic problems of sequentially increased complexity. An LLM‐based pipeline could analyze genetic variants in the genomic sequences of human hearing loss or rare genetic disease patients and assist in identifying ...
Tao Tu, Khaled Saab, Weida Liu, Zhouqing Fang, Zhuanfen Cheng, Svetolik Spasic, Maja Djurisic, Hiroaki Mohri, Wenlong Ren, Anil Palepu, Juraj Gottweis, Alan Karthikesalingam, Kavita Kulkarni, Annalisa Pawlosky, Devon Bonner, Elijah Kravets, Shruti Marwaha, Hector R. Mendez, Matthew T. Wheeler, Jonathan A. Bernstein, Undiagnosed Diseases Network, Cheng‐Yu Tsai, Chen‐Chi Wu, Konstantina M. Stankovic, Vivek Natarajan, Gary Peltz   +25 more
wiley   +1 more source